Multi-omics identifies PCK1-associated immunometabolic regulation underlying the protective effects of sinomenine in vascular dementia
Multi-omics identifiziert eine mit PCK1 assoziierte immunometabolische Regulation als Grundlage der protektiven Effekte von Sinomenin bei vaskulärer Demenz
Frontiers in Pharmacology · 29.10.2026 · 17
DOI: 10.3389/fphar.2026.1979177 ↗Auf einen Blick
Multi-omics-Analysen und Zellversuche deuten darauf hin, dass Sinomenin bei vaskulärer Demenz microgliale Störungen über PCK1-assoziierte immunometabolische Veränderungen abschwächt.
Fragestellung
Welche molekularen Mechanismen vermitteln die schützenden Effekte von Sinomenin bei vaskulärer Demenz?
Methode
Transcriptom-Integration, WGCNA, Netzwerkpharmakologie und single-nucleus RNA-Sequenzierung zur Zielidentifikation; molekulares Docking und Moleküldynamik; Validierung in LPS-stimulierten BV2-Mikroglia.
Ergebnisse
PCK1 wurde als möglicher Mediator identifiziert. SIN band stabil an PCK1, senkte in LPS-stimulierten BV2-Mikroglia die Entzündungsaktivierung, erhöhte PCK1 und verbesserte Bioenergetik und Redox-Parameter.
Schlussfolgerung der Autor:innen
Die Autor:innen schließen, dass SIN VaD-assoziierte mikrogliale Dysfunktion durch Modulation PCK1-assoziierter immunometabolischer Veränderungen lindert.
Kernaussagen
- PCK1 wurde als relevanter Mediator von SIN identifiziert.
- SIN hemmte Entzündung und verbesserte Stoffwechselparameter in BV2-Zellen.
- Mikrogliale immunometabolische Regulation wird als Ziel bei VaD hervorgehoben.
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 29.10.2026. Verfasst von Wanling Ren und 6 weiteren Autor:innen. Beteiligte Einrichtung: Traditional Chinese Medicine Rehabilitation Research Team, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Chi…. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Background
Vascular dementia (VaD) is one of the major causes of cognitive impairment among older adults. However, effective treatments that can modify the progression of the disease are still lacking. Emerging evidence indicates that metabolic remodeling in microglia influences inflammatory responses during vascular brain injury. Microglial immunometabolic regulation has therefore been proposed as an important contributor to the pathogenesis of vascular dementia (VaD).
Methods
Transcriptomic integration, WGCNA, network pharmacology, and single-nucleus RNA sequencing were combined to identify disease-associated microglial alterations and potential targets involved in sinomenine (SIN)-mediated regulation. The interaction between SIN and phosphoenolpyruvate carboxykinase 1 (PCK1) was investigated using molecular docking and molecular dynamics simulations. The biological effects of SIN were then validated in lipopolysaccharide (LPS)-stimulated BV2 microglia.
Results
Integrated analyses highlighted PCK1 as a potential mediator associated with SIN-induced metabolic regulation in VaD. snRNA-seq demonstrated expansion of metabolically stressed microglial states accompanied by PCK1-related metabolic alterations. Stable binding between SIN and PCK1 was supported by molecular docking and molecular dynamics simulations. In LPS-stimulated BV2 microglia, SIN suppressed inflammatory activation, restored PCK1 expression, attenuated inflammation-associated metabolic remodeling, improved cellular bioenergetics, and modulated metabolic redox-related parameters. SIN also enhanced adaptive stress responses through regulation of CRYAB, APOD, and HSPH1.
Conclusion
Collectively, these findings suggest that SIN alleviates VaD-associated microglial dysfunction by modulating PCK1-associated immunometabolic alterations. They expand the current understanding of the pharmacological actions of SIN and highlight microglial immunometabolic regulation as a potential therapeutic target for VaD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Traditional Chinese Medicine Rehabilitation Research Team, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
- School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.
- The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
- Rehabilitation Department, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
- Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
Zitieren
APA
Ren, W., Wang, Z., Yang, W., Rao, Y., Qiu, Z., Li, J., & Ou, H. (2026). Multi-omics identifies PCK1-associated immunometabolic regulation underlying the protective effects of sinomenine in vascular dementia. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1979177
Vancouver
Ren W, Wang Z, Yang W, Rao Y, Qiu Z, Li J, et al. Multi-omics identifies PCK1-associated immunometabolic regulation underlying the protective effects of sinomenine in vascular dementia. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1979177
BibTeX
@article{Ren2026,
author = {Ren, Wanling and Wang, Zipu and Yang, Weisi and Rao, Yuan and Qiu, Zhiqing and Li, Jing and Ou, Haining},
title = {Multi-omics identifies PCK1-associated immunometabolic regulation underlying the protective effects of sinomenine in vascular dementia},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1979177}
}
EUVIMED